What Hilotherm does

Hilotherm is a UK-based private medical device company founded in 2014 that specialises in temperature-controlled cooling therapy, branded as Hilotherapy. Its core product is the HTP1 device, a closed-loop water circulation system that pumps temperature-regulated water (typically 15-20°C depending on indication) through anatomically shaped cuffs to deliver continuous, precise cooling for post-operative pain, swelling, and bruising management, and as a platform for its ChemoCare line, which prevents chemotherapy-induced peripheral neuropathy (CIPN) and hair loss in oncology patients.

The company operates two distinct go-to-market motions. For post-operative recovery, it runs a direct-to-consumer rental model: patients rent the HTP1 weekly (£140-£186 first week, £45/week extensions) with cuffs/masks sold separately (£38-£98), delivered and collected via DPD across mainland UK. For ChemoCare, it sells directly to hospitals and oncology centres (GenesisCare, Ramsay, Spire, Clatterbridge Cancer Centre, and various NHS trusts), where devices are used during IV chemotherapy sessions rather than rented by individual patients. Hilotherm is used in over 70 UK hospitals, backed by published clinical studies including a 577-patient real-world breast cancer trial showing 94.1% protection from severe CIPN and an RJAH NHS Trust knee replacement study demonstrating reduced length of stay and analgesia use.

The business is headquartered in Warwick, UK (relocated February 2026 to Olympus Court, Tachbrook Park) with 11-50 employees. Revenue is not publicly disclosed, but the recurring rental model combined with institutional hardware sales and a broadening cuff/accessory catalogue indicates a diversified medical device revenue mix. Growth signals include new hospital partnerships, expanding clinical evidence, and an extended oncology footprint via scalp cooling (ChemoCare CIA), though commercial operations remain UK-bounded.

Name

Hilotherm

Legal name

Hilotherm

Website

https://hilotherm.co.uk

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Hilotherm is a UK medical device company (founded 2014) that rents and sells temperature-controlled cooling devices (HTP1 and ChemoCare lines) for post-operative recovery and chemotherapy side-effect prevention, serving individual patients via direct rental and hospitals including NHS trusts, GenesisCare, Ramsay, and Spire.

Ownership category

akta.pro rank

Product category

Medical Cryotherapy Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Air Quality & Environmental Infection Control (HEPA Filtration, Isolation Barriers, CSSD/HVAC Solutions) (HLAHANAK)

Keywords

• Temperature-controlled cooling therapy
• Post-operative cryotherapy devices
• Chemotherapy side effect prevention
• Medical cooling equipment rental
• CIPN prevention therapy

Headquarters

HQ city

Coventry

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. HTP1 Device Rental: Hilotherm generates revenue primarily through rental of the HTP1 cooling device. Patients rent the device on a weekly basis. The rental includes delivery and collection of the device via DPD. Additional cuffs/masks can be purchased separately. Rental extensions are available on a weekly basis. Average rental periods are 1-2 weeks for facial/jaw surgery and 2-4 weeks for orthopaedic/knee surgery.
2. Cuff/Mask Sales: Patients purchase single-use cuffs and masks (face masks, knee cuffs, etc.) either separately or bundled with device rental. Hospitals also supply single-patient-use cuffs to patients who use Hilotherm in hospital, which they take home.
3. ChemoCare Institutional Supply: Hilotherm ChemoCare devices are provided to hospitals and oncology centers (GenesisCare, Ramsay, Spire, NHS hospitals) for use during chemotherapy treatments. Patients cannot rent ChemoCare devices directly as they must be used during IV chemotherapy under medical supervision.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Hilotherm develops, manufactures, and rents the HTP1, a precision temperature-controlled cooling device that circulates water through anatomically shaped cuffs and masks to reduce post-operative pain, swelling, and bruising. The company also supplies ChemoCare devices to hospitals and oncology centres for the prevention of chemotherapy-induced peripheral neuropathy (CIPN) and hair loss during cancer treatment. Devices are rented directly to patients on a weekly basis or deployed institutionally through hospital partnerships across the UK.

Product overview

Hilotherm is a medical device company offering temperature-controlled cooling therapy (Hilotherapy) solutions for post-operative recovery and chemotherapy side effect management. The product portfolio centers on the HTP1 device—a precision temperature-controlled cooling unit that circulates water through specialized cuffs and masks at precisely maintained temperatures. For post-operative use, the HTP1 operates at 15°C-19°C to reduce pain, swelling, and bruising following oral/maxillofacial, orthopedic, and cosmetic surgeries. The ChemoCare product line extends the platform for cancer care: ChemoCare CIPN provides hand-foot cooling at 15°C-17°C to prevent chemotherapy-induced peripheral neuropathy, while ChemoCare CIA delivers scalp cooling at 19-20°C to reduce chemotherapy-induced hair loss. The offering is primarily rental-based (device from £140/week) with single-patient-use cuffs and masks sold separately (ranging from £38-£98). Hilotherm does not use ice—its regulated temperature allows continuous safe use without cold-related tissue damage risks.

Differentiator

Problem solved

Functional benefit

Brands

• ChemoCare: Temperature-controlled cooling system for chemotherapy patients to prevent chemotherapy-induced peripheral neuropathy (CIPN), hand-foot syndrome, and hair loss.
• Hilotherapy

Products and services

• Hilotherm HTP1 Device The primary temperature-controlled cooling therapy device that pumps water through specialized cuffs at precise temperatures (15°C–19°C depending on indication) to reduce post-operative pain, swelling, and bruising. Available for weekly rental by individual patients in the UK.
• ChemoCare CIPN (Hand and Foot Cooling System) Institutional cooling system for hospitals and oncology centres that prevents chemotherapy-induced peripheral neuropathy (CIPN) and hand-foot syndrome by cooling patient extremities at 15°C–17°C before, during, and after chemotherapy infusion. Used at GenesisCare, Ramsay, Spire, Clatterbridge Cancer Centre, and NHS hospitals.
• ChemoCare CIA (Scalp Cooling System) Temperature-controlled scalp cooling system that maintains scalp temperature at 19°C–20°C to constrict blood vessels at hair roots, reducing uptake of cytotoxic substances by hair follicles and preventing chemotherapy-induced alopecia. Can be used simultaneously with ChemoCare CIPN hand/foot cooling.
• Lower Face Cuff with Link Specialized face mask accessory for the HTP1 device, designed for jaw and maxillofacial surgery recovery. Includes a link section cooling between the top lip and nose. Preferred by consultants for double jaw surgery. Priced at £48.
• Lower Face Cuff without Link Face mask accessory for the HTP1 device, designed for cosmetic facial surgery recovery (facelifts, neck lifts) without the link section between top lip and nose. Priced at £49.
• Knee Cuff Anatomically shaped knee cuff accessory for the HTP1 device, providing continuous cooling at 15°C–18°C following total knee replacement, ACL, osteotomy, and fracture surgery. Priced at £89.
• Trapezoidal Cuff Cuff accessory for the HTP1 device, designed for shoulder and hip surgery recovery. Priced at £98.
• Foot Cuff Cuff accessory for the HTP1 device, designed for foot surgery recovery including bunionectomy. Priced at £94.
• Nose Cuff Specialized cuff accessory for the HTP1 device, designed for rhinoplasty recovery. Priced at £47.
• Open Eye Cuff Cuff accessory for the HTP1 device, designed for blepharoplasty (eyelid surgery) recovery with an opening for the eyes. Priced at £38.
• Closed Eye Cuff Cuff accessory for the HTP1 device, designed for eye surgery recovery with a closed design. Priced at £39.
• Upper Face Cuff Cuff accessory for the HTP1 device, designed for upper facial procedures. Priced at £51.

Quantifiable outcome

• 94.1% of 577 breast cancer patients were free of severe CIPN symptoms at end of treatment; 90.1% had zero or mild symptoms during treatment
• +5 more outcomes

Named customers13 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• GenesisCarecoreStrategic or Co-development PartnerGenesisCare offers Hilotherm ChemoCare to their chemotherapy patients in the UK to prevent chemotherapy-induced peripheral neuropathy (CIPN) and hand-foot syndrome. This is a key institutional partnership for the ChemoCare product line.
• The Clatterbridge Cancer CentrecoreStrategic or Co-development PartnerThe Clatterbridge Cancer Centre offers Hilotherm ChemoCare hand and foot cooling to their patients. Their ChemoCare trial was featured in the Daily Mail (Mail on Sunday), raising awareness of CIPN prevention. Featured as pioneering cooling technology in cancer care.
• Ramsay Health CarecoreStrategic or Co-development PartnerRamsay Health Care hospitals in the UK offer Hilotherm ChemoCare to their chemotherapy patients.
• Spire HealthcarecoreStrategic or Co-development PartnerSpire Healthcare hospitals in the UK offer Hilotherm ChemoCare to their chemotherapy patients.
• Various NHS HospitalscoreStrategic or Co-development PartnerSeveral NHS hospitals across the UK use Hilotherm for post-operative care (70+ hospitals use Hilotherapy following jaw surgery) and ChemoCare for chemotherapy support.
• Center for Gynecologic Oncology in DüsseldorfcoreStrategic or Co-development PartnerConducted one of the largest real-world studies on device-controlled cryotherapy for CIPN prevention, tracking 577 breast cancer patients using Hilotherm ChemoCare. Study presented at ESMO Breast Cancer Congress, demonstrating 94.1% protection from severe CIPN symptoms.
• The Royal MarsdencoreStrategic or Co-development PartnerThe Royal Marsden is conducting a clinical evaluation of controlled cooling therapy for CIPN prevention using Hilotherm devices.
• Robert Jones and Agnes Hunt (RJAH) NHS Foundation TrustcoreStrategic or Co-development PartnerConducted controlled trial using Hilotherapy with 61 total knee replacement patients, published in medical literature. Results showed reduction in length of stay and analgesia requirements.
• Hampshire Hospitals NHS Foundation TrustminorStrategic or Co-development PartnerHampshire Hospitals introduced Hilotherm ChemoCare to help chemotherapy patients with side effects including CIPN. Featured in Hampshire Chronicle.
• University of Warwick Science Park / Venture CentreminorOthersPreviously operated from the Venture Centre and University of Warwick Science Park before relocating to new offices at Olympus Court, Warwick in February 2026.

Scale indicators6 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• Enovis (DJO Global): Large orthopaedic and recovery device company (formerly DJO) with cold therapy, bracing and rehabilitation products; comparable to Hilotherm as a broad incumbent in the post-operative recovery space with overlapping clinician customers.
• 3M Health Care (formerly Acelity/KCI): Major medical device group whose KCI/Acelity unit markets cryotherapy and temperature-controlled wound therapy products; comparable to Hilotherm as a broad incumbent exploring cryotherapy applications.
• Össur: Global orthopaedic device company offering braces, supports and post-operative recovery products; comparable to Hilotherm as a broader orthopaedic recovery incumbent that overlaps on knee, shoulder and post-op indications.
• Halyard Health (Owens & Minor): Global medical supplies and devices company with hospital-channel distribution; comparable as a broad medical disposables/devices incumbent serving the same hospital and surgical customer base that Hilotherm sells into.

Direct peers

• Breg: Manufactures cold therapy devices (Polar Care, Kodiak) widely used after orthopaedic surgery; comparable to Hilotherm in indication (post-op orthopaedic recovery) and channel (surgeon-prescribed home rental/retail).
• Dignitana: Swedish-listed developer of the DigniCap scalp cooling system for chemotherapy-induced hair loss; comparable to Hilotherm ChemoCare CIA as a competing scalp-cooling device sold to oncology centres.
• Game Ready (Coolsystems): Market-leading provider of post-operative cold and compression therapy systems used in orthopaedic and sports medicine recovery — directly comparable to Hilotherm's HTP1 device on indication, target customer (post-surgical patients) and clinician referral channel.
• Paxman Scalp Cooling: UK-based leader in chemotherapy-induced alopecia (CIA) scalp cooling systems sold to NHS and private oncology centres; directly competes with Hilotherm ChemoCare CIA on the same scalp cooling indication.

Others

• Medline Industries: Large private medical supplies manufacturer and distributor with deep UK hospital relationships; relevant ecosystem peer given Hilotherm's hospital procurement-driven ChemoCare channel.

Emerging players

• Penguin Cold Caps: Provides non-machine-controlled cold cap systems for chemotherapy-induced hair loss; overlaps with Hilotherm ChemoCare CIA on the scalp cooling indication via a different (gel cap) delivery mechanism.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubem.youtube.com/user/Hilotherapy
• Instagraminstagram.com/hilotherm
• Xx.com/hilotherapy
• LinkedInlinkedin.com/company/hilotherapy-uk-ltd

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hilotherm